BURE EQUITY AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.8 SEK | -2.00% |
|
-1.41% | +12.67% |
| Feb. 22 | Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 22 | Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | -9.17B -840M | Sales 2023 | 4.81B 440M | Capitalization | 21.19B 1.94B |
|---|---|---|---|---|---|
| Net income 2022 | -9.24B -847M | Net income 2023 | 4.74B 435M | EV / Sales 2022 | -1.93 x |
| Net cash position 2022 | 529M 48.45M | Net cash position 2023 | 1.57B 144M | EV / Sales 2023 | 4.08 x |
| P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
4.47
x | Employees | 10 |
| Yield 2022 |
0.91% | Yield 2023 |
0.87% | Free-Float | 70.61% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.61% | ||
| 1 week | -0.60% | ||
| Current month | -3.91% | ||
| 1 month | -2.37% | ||
| 3 months | +16.97% | ||
| 6 months | +45.62% | ||
| Current year | +15.26% |
1 week
321.60
337.40
1 month
315.20346.00
Current year
272.40346.00
1 year
202.20346.00
3 years
171.30489.20
5 years
126.40489.20
10 years
26.40489.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 98-12-31 | |
Max Jonson
DFI | Director of Finance/CFO | 56 | 13-09-30 |
| Chairman | 60 | 98-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 19-04-30 | |
| Chairman | 60 | 98-12-31 | |
| Director/Board Member | 70 | 16-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 233 M€ | +7.91% | ||
| 0.01% | 773 M€ | 0.00% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 322.6 | -2.06% | 21 709 |
| 24-04-15 | 329.4 | +0.61% | 31,497 |
| 24-04-12 | 327.4 | 0.00% | 34,458 |
| 24-04-11 | 327.4 | +0.18% | 31,597 |
| 24-04-10 | 326.8 | +0.06% | 44,019 |
Delayed Quote Nasdaq Stockholm, April 15, 2024 at 11:29 am EDT
More quotes
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Sector
Investment Holding Companies
Calendar
2024-05-06
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +15.26% | 2.23B | |
| +12.66% | 73.13B | |
| +52.61% | 17.01B | |
| +7.13% | 16.34B | |
| +9.27% | 14.12B | |
| -0.13% | 12.41B | |
| +11.95% | 12.19B | |
| +3.43% | 10.88B | |
| +30.12% | 10.14B | |
| -1.50% | 9.61B |
- Stock Market
- Equities
- BURE Stock
